Prevalence of monoclonal proteins in patients with isolated hypogammaglobulinemia on serum protein electrophoresis
- 14 November 2024
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 84 (7-8) , 510-514
Abstract
Isolated hypogammaglobulinemia (IH) is an electrophoretic pattern that can be encountered on serum protein electrophoresis (SPEP) and is defined as a decreased but morphologically normal γ-globulin fraction with normal α- and β-globulin fractions. SPEP is mainly used to detect monoclonal proteins which are usually observed as additional peaks in the electropherogram. However, they may also be more discretely present in a significant proportion of patients presenting with IH. Therefore, we aimed to evaluate i) via both retrospective and prospective analysis to what extent paraproteins as identified by immunofixation are present in patients demonstrating IH on SPEP and ii) whether other parameters may predict their presence in IH-patients. For this purpose, we first reviewed historic SPEP- and immunofixation results in our tertiary hospital and determined paraprotein prevalence in this retrospective cohort. This analysis showed immunofixation was requested in only 519/3938 (13.2%) historic IH-results with 52/519 (10%) patients demonstrating paraproteins. Next, various laboratory parameters were compared between paraprotein-positive and -negative patients and subjected to logistic regression models but regrettably, no parameter could be retained as promising predictor of paraproteins. Lastly, to confirm paraprotein prevalence seen in the historical query, we conducted a six-month prospective analysis during which immunofixation was requested more frequently in IH-cases during routine diagnostics and which showed paraproteins to be present in 20/83 (24.1%) of IH-patients. Hence, as up to 24% of patients with IH may harbour paraproteins, one should consider performing follow-up analyses (e.g. immunofixation, urine electrophoresis and/or free light chain analysis) for all IH-cases identified via SPEP.Keywords
This publication has 13 references indexed in Scilit:
- Investigation and management of the monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 2023
- On the path to evidence-based reporting of serum protein electrophoresis patterns in the absence of a discernible monoclonal protein – A critical review of literature and practice suggestionsClinical Biochemistry, 2018
- Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working GroupClinical Biochemistry, 2018
- Value of reflex testing based on hypogammaglobulinemia as demonstrated in serum protein electrophoresisClinical Biochemistry, 2015
- Multiple Comparison ProceduresJAMA, 2014
- Specificity of Serum and Urine Protein Electrophoresis for the Diagnosis of Monoclonal GammopathiesClinical Chemistry, 2010
- UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)British Journal of Haematology, 2009
- Detection by Immunofixation of M Proteins in Hypogammaglobulinemic Patients With Normal Serum Protein Electrophoresis ResultsAmerican Journal of Clinical Pathology, 2007
- Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple MyelomaClinical Cancer Research, 2005
- Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light ChainsClinical Chemistry, 2002